title: A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients.
authors.affiliation: Royal Liverpool University Hospital, England.
authors.forename: R A
authors.initials: RA
authors.lastname: Sells
authors.forename: A
authors.initials: A
authors.lastname: Bakran
authors.forename: M W
authors.initials: MW
authors.lastname: Brown
authors.forename: J
authors.initials: J
authors.lastname: Grinyo
authors.forename: A
authors.initials: A
authors.lastname: Hammad
authors.forename: D
authors.initials: D
authors.lastname: Hyatt
authors.forename: G
authors.initials: G
authors.lastname: Owens
mesh_terms: D002102:Cadaver; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011183:Postoperative Complications; D011446:Prospective Studies; D015996:Survival Rate; D014019:Tissue Donors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid